| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | YASO THERAPEUTICS INCORPORATED | 712 BAXTER TRL | FATE | TX | 75087-9295 | ROCKWALL | USA | R44HD118927 | First in Human Clinical Trial of a Contraceptive MPT YASO GEL | 000 | 1 | NIH | 4/1/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $545,966 ) |
| | 2025 | 2025 | YASO THERAPEUTICS INCORPORATED | 712 BAXTER TRL | FATE | TX | 75087-9295 | ROCKWALL | USA | R44HD118927 | First in Human Clinical Trial of a Contraceptive MPT YASO GEL | 000 | 1 | NIH | 9/11/2025 | $545,966 |
| | 2025 | 2025 | YASO THERAPEUTICS INCORPORATED | 712 BAXTER TRL | FATE | TX | 75087-9295 | ROCKWALL | USA | R44HD118927 | First in Human Clinical Trial of a Contraceptive MPT YASO GEL | 001 | 1 | NIH | 9/24/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | YASO THERAPEUTICS INCORPORATED | 7460 WARREN PKWY STE 100 | FRISCO | TX | 75034-4170 | DENTON | USA | R43HD109101 | Preparation and submission of an IND for PPCM Gel contraceptive | 000 | 1 | NIH | 12/22/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | YASO THERAPEUTICS INCORPORATED | 7460 WARREN PKWY STE 100 | FRISCO | TX | 75034-4170 | DENTON | USA | R43HD109101 | Preparation and submission of an IND for PPCM Gel contraceptive | 000 | 1 | NIH | 10/11/2022 | $0 |
| | 2023 | 2020 | YASO THERAPEUTICS INCORPORATED | 7460 WARREN PKWY STE 100 | FRISCO | TX | 75034-4170 | DENTON | USA | R44HD092206 | Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND | 000 | 4 | NIH | 5/15/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $298,521 ) |
| | 2022 | 2022 | YASO THERAPEUTICS INCORPORATED | 7460 WARREN PKWY STE 100 | FRISCO | TX | 75034-4170 | DENTON | USA | R43HD109101 | Preparation and submission of an IND for PPCM Gel contraceptive | 000 | 1 | NIH | 4/7/2022 | $298,521 |
|
| Issue Date FY: 2020 ( Subtotal = $984,778 ) |
| | 2020 | 2020 | YASO THERAPEUTICS INCORPORATED | 15333 N PIMA RD STE 305 OFC 345 | SCOTTSDALE | AZ | 85260-2717 | MARICOPA | USA | R44HD092206 | Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND | 000 | 4 | NIH | 4/28/2020 | $984,778 |
|
| Issue Date FY: 2019 ( Subtotal = $999,102 ) |
| | 2019 | 2019 | YASO THERAPEUTICS INCORPORATED | 15333 N PIMA RD STE 305 OFC 345 | SCOTTSDALE | AZ | 85260-2717 | MARICOPA | USA | R44HD092206 | Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND | 002 | 3 | NIH | 8/8/2019 | $96,747 |
| | 2019 | 2019 | YASO THERAPEUTICS INCORPORATED | 20860 N TATUM BLVD STE 300 OFFICE 320 | PHOENIX | AZ | 85050-4283 | MARICOPA | USA | R44HD092206 | Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND | 000 | 3 | NIH | 3/8/2019 | $999,102 |
| | 2019 | 2018 | YASO THERAPEUTICS INCORPORATED | 15333 N PIMA RD STE 305 OFC 345 | SCOTTSDALE | AZ | 85260-2717 | MARICOPA | USA | R44HD092206 | Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND | 001 | 2 | NIH | 8/8/2019 | -$96,747 |
|
| Issue Date FY: 2018 ( Subtotal = $982,217 ) |
| | 2018 | 2018 | YASO THERAPEUTICS INCORPORATED | 20860 N TATUM BLVD STE 300 OFFICE 320 | PHOENIX | AZ | 85050-4283 | MARICOPA | USA | R44HD092206 | Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND | 000 | 2 | NIH | 4/27/2018 | $982,217 |
|
| Issue Date FY: 2017 ( Subtotal = $985,250 ) |
| | 2017 | 2017 | YASO THERAPEUTICS INCORPORATED | 20860 N TATUM BLVD STE 300 OFFICE 320 | PHOENIX | AZ | 85050-4283 | MARICOPA | USA | R44HD092206 | Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND | 000 | 1 | NIH | 5/5/2017 | $985,250 |
| | 2017 | 2014 | YASO THERAPEUTICS INCORPORATED | 20860 N TATUM BLVD STE 300 OFFICE 320 | PHOENIX | AZ | 85050-4283 | MARICOPA | USA | R44AI084225 | Continuing Development of PPCM Vaginal Contraceptive Microbicide | 000 | 3 | NIH | 1/31/2017 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $1,000,000 ) |
| | 2014 | 2014 | YASO BIOTECHNOLOGY INC | 106 NORTH DENTON TAP ROAD | COPPELL | TX | 75019 | DALLAS | USA | R44AI084225 | Continuing Development of PPCM Vaginal Contraceptive Microbicide | 000 | 3 | NIH | 7/24/2014 | $1,000,000 |
|
| Issue Date FY: 2013 ( Subtotal = $1,000,000 ) |
| | 2013 | 2013 | YASO BIOTECHNOLOGY INC | 106 NORTH DENTON TAP ROAD | COPPELL | TX | 75019 | DALLAS | USA | R44AI084225 | Continuing Development of PPCM Vaginal Contraceptive Microbicide | 000 | 2 | NIH | 7/31/2013 | $1,000,000 |
|
| Issue Date FY: 2011 ( Subtotal = $285,612 ) |
| | 2011 | 2011 | YASO BIOTECHNOLOGY INC | 106 NORTH DENTON TAP ROAD | COPPELL | TX | 75019 | DALLAS | USA | R43AI084225 | PRE-CLINICAL DEVELOPMENT OF PPCM VAGINAL MICROBICIDE | 002 | 1 | NIH | 9/22/2011 | $285,612 |
| | 2011 | 2011 | YASO BIOTECHNOLOGY INC | 106 NORTH DENTON TAP ROAD | COPPELL | TX | 75019 | DALLAS | USA | R43AI084225 | PRE-CLINICAL DEVELOPMENT OF PPCM VAGINAL MICROBICIDE | 000 | 1 | NIH | 1/14/2011 | $285,612 |
| | 2011 | 2011 | YASO BIOTECHNOLOGY INC | 106 NORTH DENTON TAP ROAD | COPPELL | TX | 75019 | DALLAS | USA | R43AI084225 | PRE-CLINICAL DEVELOPMENT OF PPCM VAGINAL MICROBICIDE | 001 | 1 | NIH | 9/21/2011 | -$285,612 |
|
| Issue Date FY: 2006 ( Subtotal = $152,196 ) |
| | 2006 | 2006 | YASO BIOTECHNOLOGY INC | 106 NORTH DENTON TAP ROAD | COPPELL | TX | 75019 | DALLAS | USA | R41AI069659 | DEVELOPMENT OF SAMMA BASED VAGINAL MICROBIOCIDE | 000 | 1 | NIH | 4/10/2006 | $152,196 |
|
|
